Temps de lecture : 3 min
- Group's consolidated turnover: € 341.4 million (+16.8% at constant exchange rates, +13.0% at current exchange rate)
- EBITDA: € 58.5 million (+10.6% compared to the first quarter of 2006)
- Net profit: € 20.8 million (+22.4% compared to the first quarter of 2006)
- Net debt: € 556 million ( € 532 million at the end of 2006)
- Shareholders' equity: € 853 million (€ 839 million at the end of 2006)
The Board of Directors of Safilo Group Spa today reviewed and approved the results relating to the first quarter of 2007 and which highlight once again strong growth in turnover and a corresponding growth in net profit.
Consolidated turnover registered an increase of 16.8% at constant exchange rates, and reached a record value of 341.4 million Euro during the quarter. The growth in turnover was achieved in all worldwide markets with especially impressive results in Europe (+35%).
The quarterly performance confirms the recovery in the sale of prescription frames and underlines a balanced growth between house brands and licensed brands.
The Group's operating result has seen an improvement despite the negative impact deriving from the weakness of the US dollar, and has reached an EBITDA of 58.5 million Euro against the 52.9 million Euro of the first quarter of 2006 (+10.6%).
The increase in operating profit, not only boosted by the positive sales results, is due also to the improvements seen in the industrial area and the cost containment policies for general costs. The management of financial costs and interest has succeeded in containing financial expenses despite the slight increase in net debt due to a seasonal fluctuation of working capital which was more marked than usual.
The overall result of these improvements is a 22.4% increase in net profit, which reached 20.8 million Euro in the first quarter, against the 17.0 million Euro of the same period of the previous year.
On the basis of the first quarter results the necessary conditions exist to achieve the estimated growth as foreseen in the budget, both with regards to turnover with an increase of approximately 7% compared to last year, and with regards to EBITDA which should reach 190 million Euro at the end of 2007, an increase of 17% compared to 2006.
Vittorio Tabacchi, Chairman of Safilo Group, while commenting on the results achieved, stated: “2007 has begun with record sales in the first quarter. The new licences and the increased efficiency achieved in the production process are producing the positive results we expected.
This is further confirmation of the choices made by Safilo and its course for the future: not only have we achieved technological excellence thanks to significant investments in research and development and created a valuable capillary distribution network which we will continue to expand, but we have also a superlative brand portfolio which confirms us as worldwide leader in the high-end and luxury eyewear sector. With these solid foundations we are confident that the company will achieve the important goals it has set itself.”
Source : communiqué de presse
Vous avez la parole !
pour pouvoir poster des commentaires
Nos lecteurs ont aussi lu...
Le marché des verres de freination de la myopie pourrait tripler d’ici 2034
Publié le 21 août 2026
Encore relativement récent, le marché des verres destinés à freiner la progression de la myopie chez les enfants et adolescents pourrait connaître une forte accélération…
Safilo pointe un recul généralisé du marché de l’optique en France au 1er semestre 2026
Publié le 18 août 2026
Le groupe Safilo a réalisé un chiffre d’affaires de 512 millions d’euros au premier semestre 2026, en baisse de 4,8% à taux de change courants et de 1,9% à taux de…
[Sondage] Vous vendez ou vous ne vendez pas ? Participez au baromètre lunettes connectées
Publié le 18 août 2026
Mise à jour du 18/08/2026 : Suite à un problème technique empêchant d'aller au bout des questions, nous vous invitons à re-répondre à notre sondage. Merci pour votre…
Les dernières news
Opéré de la myopie au Lasik, il garde des séquelles : les Quinze-Vingts condamnés
Publié le 21 août 2026
Près de douze ans après une opération de la myopie, le contentieux opposant un patient au Centre hospitalier national d’ophtalmologie (CHNO) des Quinze-Vingts connaît un…
Un OVNI dans les rues de Toulouse pour faire connaître son magasin d’optique
Publié le 21 août 2026
« Chaque fois que je le sors, on me prend toujours en photo. » Difficile, il est vrai, de passer inaperçu à bord de l'engin utilisé depuis quelques mois par Thierry…
Le marché des verres de freination de la myopie pourrait tripler d’ici 2034
Publié le 21 août 2026
Encore relativement récent, le marché des verres destinés à freiner la progression de la myopie chez les enfants et adolescents pourrait connaître une forte accélération…